insights_auto
Why is EDIT down 3,01%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,77 $
arrow_downward
-3,01%(-0,055) 1D
1,82 $
arrow_upward
+2,82% (+0,050)bedtimeAfter hours
Closed: 18 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,86 $
High
1,94 $
Low
1,76 $
Mkt. cap
272,43 մլն
Avg. vol.
2,39 մլն
Volume
303,00
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,86 $
High
1,94 $
Low
1,76 $
Mkt. cap
272,43 մլն
Avg. vol.
2,39 մլն
Volume
303,00
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
BigGo Finance
·
4 ժամ առաջ
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
FOREX.com
·
4 ժամ առաջ
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
TradingView
·
3 ժամ առաջ
Stock Market: Will S&P 500 Open Up or Down Today?
FXStreet
·
11 ժամ առաջ
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc